Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
Published: Oct 21, 2009
AUSTIN, Texas--(BUSINESS WIRE)--Auxano Diagnostics, LLC, a subsidiary of Auxano Biomedical, LLC, has announced the application of the company’s breakthrough wound care technology to the treatment of dry eye syndrome (DES) with the Auxano point-of-care indicator system. Dry eye syndrome (DES) is a condition that affects millions of people worldwide. According to the Centers for Disease Control (CDC), DES can be a serious condition, which, if left untreated, can damage ocular structures.